Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Pathfinder Cell Therapy, Inc.
No Price
Closing Price OTC 27.04.2026:
0,0001 USD
27.04.2026 20:00
Current Prices from Pathfinder Cell Therapy, Inc.
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
UTC
PFND
USD
27.04.2026 20:00
0,0001 USD
0,00 USD
Company Profile for Pathfinder Cell Therapy, Inc. Share
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
